News
Radiotherapeutic companies have been ideal, but what exactly makes this company ideal, especially with its Nano-monoclonal antibodies platform? That's because it has been able to incorporate a ...
SCbio, in partnership with The Massachusetts Biotechnology Council, has selected six emerging life sciences companies to ...
Rallybio ends RLYB212 trial for FNAIT; shifts focus to RLYB116 and preclinical assets with 2025 trial milestones and $6 billion market potential.
As a global leader in digital drawing devices and solutions, Huion today announces the Kamvas Slate 11 and Kamvas Slate 13, siblings of the Kamvas Slate 10 Android tablet. This announcement ...
Imagine tiny LEGO pieces that automatically snap together to form a strong, flat sheet. Then, scientists add special chemical "hooks" to these sheets ...
5d
News Medical on MSNGold Nanoparticles Restore Vision in Macular DegenerationA new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses.
Marama Labs has launched its CloudSpec instrument for nanomedicine development, which is expected to cut time and speed up ...
KANAZAWA, Japan, April 3, 2025 /PRNewswire/ -- Nano Life Science Institute (WPI ... biomolecular markers on cell-derived vesicles using antibodies to differentiate subpopulations.
Apr. 14, 2025 — The powerful potential of nano technologies and AI to detect ... NK Cells Complexed With Bispecific Antibody Yield High Response Rates in Patients With Lymphoma Apr. 4, 2025 ...
The team stained a library of cells with fluorescently labelled antibodies for each target ... nanospray desorption electrospray ionization (nano-DESI) and a new instrument for individual ion ...
CellChat analysis elucidated the differential expression of chemokines in keratitis. After that, screening amebic nano-antibodies, synthesizing antibody-chemokine fusion proteins, and validated their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results